TY - JOUR
T1 - Personalized nanomedicine
T2 - A revolution at the nanoscale
AU - Fornaguera, Cristina
AU - García-Celma, Maria José
N1 - Funding Information:
Acknowledgments: C.F. is grateful to MINECO for their “Programa Torres Quevedo” grant.
Publisher Copyright:
© 2017 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2017/12
Y1 - 2017/12
N2 - Nanomedicine is an interdisciplinary research field that results from the application of nanotechnology to medicine and has the potential to significantly improve some current treatments Specifically, in the field of personalized medicine, it is expected to have a great impact in the near future due to its multiple advantages, namely its versatility to adapt a drug to a cohort of patients. In the present review, the properties and requirements of pharmaceutical dosage forms at the nanoscale, so-called nanomedicines, are been highlighted. An overview of the main current nanomedicines in pre-clinical and clinical development is presented, detailing the challenges to the personalization of these therapies. Next, the process of development of novel nanomedicines is described, from their design in research labs to their arrival on the market, including considerations for the design of nanomedicines adapted to the requirements of the market to achieve safe, effective, and quality products. Finally, attention is given to the point of view of the pharmaceutical industry including regulation issues applied to the specific case of personalized medicine. The authors expect this review to be a useful overview of the current state of the art of nanomedicine research and industrial production, and the future opportunities of personalized medicine in the upcoming years The authors encourage the development and marketing of novel personalized nanomedicines.
AB - Nanomedicine is an interdisciplinary research field that results from the application of nanotechnology to medicine and has the potential to significantly improve some current treatments Specifically, in the field of personalized medicine, it is expected to have a great impact in the near future due to its multiple advantages, namely its versatility to adapt a drug to a cohort of patients. In the present review, the properties and requirements of pharmaceutical dosage forms at the nanoscale, so-called nanomedicines, are been highlighted. An overview of the main current nanomedicines in pre-clinical and clinical development is presented, detailing the challenges to the personalization of these therapies. Next, the process of development of novel nanomedicines is described, from their design in research labs to their arrival on the market, including considerations for the design of nanomedicines adapted to the requirements of the market to achieve safe, effective, and quality products. Finally, attention is given to the point of view of the pharmaceutical industry including regulation issues applied to the specific case of personalized medicine. The authors expect this review to be a useful overview of the current state of the art of nanomedicine research and industrial production, and the future opportunities of personalized medicine in the upcoming years The authors encourage the development and marketing of novel personalized nanomedicines.
KW - Nanodrugs
KW - Nanosystems
KW - Nanotherapeutics
KW - Personalized nanomedicine
KW - Scale-up nanomedicines market
KW - Stakeholders
UR - http://www.scopus.com/inward/record.url?scp=85032570122&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_univeritat_ramon_llull&SrcAuth=WosAPI&KeyUT=WOS:000457947300003&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.3390/jpm7040012
DO - 10.3390/jpm7040012
M3 - Review
C2 - 29023366
AN - SCOPUS:85032570122
SN - 2075-4426
VL - 7
JO - Journal of Personalized Medicine
JF - Journal of Personalized Medicine
IS - 4
M1 - 12
ER -